Brokerages Set Paysign, Inc. (NASDAQ:PAYS) PT at $8.56

Paysign, Inc. (NASDAQ:PAYS) has been given a consensus recommendation of “Moderate Buy” by the five research firms that are presently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $8.5625.

Several research analysts recently issued reports on PAYS shares. DA Davidson reaffirmed a “buy” rating and set a $9.00 target price on shares of Paysign in a research report on Thursday, November 13th. Wall Street Zen upgraded shares of Paysign from a “hold” rating to a “buy” rating in a report on Saturday, November 15th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Paysign in a research report on Wednesday, October 8th.

Insider Activity

In other news, insider Robert Strobo sold 20,000 shares of Paysign stock in a transaction on Friday, December 12th. The shares were sold at an average price of $5.47, for a total transaction of $109,400.00. Following the completion of the sale, the insider directly owned 327,290 shares in the company, valued at approximately $1,790,276.30. The trade was a 5.76% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 22.40% of the company’s stock.

Hedge Funds Weigh In On Paysign

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Rhumbline Advisers lifted its position in Paysign by 4.7% during the 2nd quarter. Rhumbline Advisers now owns 48,770 shares of the company’s stock worth $351,000 after acquiring an additional 2,183 shares during the period. Invesco Ltd. lifted its holdings in shares of Paysign by 19.1% during the second quarter. Invesco Ltd. now owns 16,942 shares of the company’s stock worth $122,000 after purchasing an additional 2,716 shares during the period. Intech Investment Management LLC lifted its holdings in shares of Paysign by 18.0% during the third quarter. Intech Investment Management LLC now owns 17,851 shares of the company’s stock worth $112,000 after purchasing an additional 2,723 shares during the period. Alliancebernstein L.P. boosted its position in Paysign by 11.6% in the third quarter. Alliancebernstein L.P. now owns 29,930 shares of the company’s stock valued at $188,000 after buying an additional 3,100 shares during the last quarter. Finally, BNP Paribas Financial Markets increased its holdings in Paysign by 99.8% in the 3rd quarter. BNP Paribas Financial Markets now owns 6,912 shares of the company’s stock worth $43,000 after buying an additional 3,453 shares during the period. Hedge funds and other institutional investors own 25.89% of the company’s stock.

Paysign Stock Down 0.5%

NASDAQ:PAYS opened at $5.49 on Wednesday. The stock has a market capitalization of $302.17 million, a price-to-earnings ratio of 42.23 and a beta of 0.93. Paysign has a 52 week low of $1.80 and a 52 week high of $8.88. The firm has a 50 day moving average of $5.36 and a 200 day moving average of $5.83.

Paysign (NASDAQ:PAYS) last issued its quarterly earnings results on Wednesday, November 12th. The company reported $0.04 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.04. Paysign had a return on equity of 19.18% and a net margin of 10.10%.The business had revenue of $21.60 million for the quarter, compared to the consensus estimate of $19.92 million. Paysign has set its FY 2025 guidance at 0.120-0.130 EPS. As a group, analysts expect that Paysign will post 0.21 EPS for the current year.

Paysign Company Profile

Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.